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Abstract
Objective To evaluate the use of a computerised
support system for decision making for implementing
evidence based clinical guidelines for the
management of asthma and angina in adults in
primary care.
Design A before and after pragmatic cluster
randomised controlled trial utilising a two by two
incomplete block design.
Setting 60 general practices in north east England.
Participants General practitioners and practice
nurses in the study practices and their patients aged
18 or over with angina or asthma.
Main outcome measures Adherence to the
guidelines, based on review of case notes and patient
reported generic and condition specific outcome
measures.
Results The computerised decision support system
had no significant effect on consultation rates, process
of care measures (including prescribing), or any
patient reported outcomes for either condition. Levels
of use of the software were low.
Conclusions No effect was found of computerised
evidence based guidelines on the management of
asthma or angina in adults in primary care. This was
probably due to low levels of use of the software,
despite the system being optimised as far as was
technically possible. Even if the technical problems of
producing a system that fully supports the
management of chronic disease were solved, there
remains the challenge of integrating the systems into
clinical encounters where busy practitioners manage
patients with complex, multiple conditions.
Introduction
Despite the current interest in clinical guidelines there
remains uncertainty about how best to introduce them
into routine practice. A systematic review suggested the
use of patient specific prompts at the time of consulta›
tion, which can be achieved with a computerised
support system for decision making—that is, “a system
that compares patient characteristics with a knowledge
base and then guides a health provider by offering
patient specific and situation specific advice.”1 2 A
recent systematic review of 68 controlled trials
examined the effectiveness of such systems.3 They were
shown to be beneficial: nine of 15 trials of systems to
improve drug dosing; one of five trials evaluating diag›
nostic aids; 14 of 19 trials evaluating systems to
improve preventive care; and 19 of 26 trials evaluating
“other” medical care such as the management of
disease in hospital and ordering tests. Improvements
were found in six of the 14 studies measuring patient
outcomes. However, the authors reported that most of
the studies had flaws in design or analysis so that the
findings should be interpreted with caution. Moreover,
no studies were identified in the management of
chronic disease in primary care or in computerised
decision support systems integrated into routine com›
puter systems in primary care.
We undertook a pragmatic cluster randomised
controlled trial of a computerised decision support
system to implement clinical guidelines for the
management of asthma and angina in adults in
primary care.
Methods
Our study methods are reported in detail elsewhere.4 5
We chose as chronic illnesses angina and asthma in
adults; these diseases are predominantly cared for in
primary care and are important because of their mor›
bidity and mortality. We developed evidence based
guidelines for the two conditions.6 7 Our study was
approved by the appropriate multicentre research
ethics committee.
Study general practices
We chose the study practices because their computer
systems were extensively used. General practices in
north east England were eligible to participate if at
least 50% of the doctors reported using one of two
computer systems to view clinical data and to issue
prescriptions during consultations. We excluded single›
handed practices as they had too few patients for the
required sample size.
Study patients
Study patients were those registered with the
participating practices, aged 18 or over with angina or
Centre for Health
Services Research,
University of
Newcastle,
Newcastle upon
Tyne NE2 4AA
Martin Eccles
professor of clinical
effectiveness
Elaine McColl
national primary care
career scientist
Nick Steen
statistician
Nikki Rousseau
research associate
Health Services
Research Unit,
University of
Aberdeen,
Aberdeen
AB25 2ZD
Jeremy Grimshaw
professor
Department of
Economics, City
University, London
EC1V 0HB
David Parkin
professor of health
economics
Sowerby Centre for
Health Informatics,
University of
Newcastle,
Newcastle upon
Tyne NE2 4AB
Ian Purves
professor
Correspondence to:
M Eccles
martin.eccles@
ncl.ac.uk
bmj.com 2002;325:941
page 1 of 7BMJ VOLUME 325 26 OCTOBER 2002 bmj.com
asthma. They were identified from a computerised
search for relevant codes for the conditions, their man›
agement, and drug treatment.
Study design and power
Our study was a before and after, cluster randomised
controlled trial utilising a two by two incomplete block
design. We allocated general practices to one of two
groups by a computerised randomisation process,
stratified by computer system and by the vocational
training status of the general practices (as a proxy for
being innovative).8 One group received computerised
guidelines for the management of angina and
provided intervention patients for the management of
angina and control patients for the management of
asthma. The other received computerised guidelines
for the management of asthma and provided
intervention patients for the management of asthma
and control patients for the management of angina.
We regarded our design as two embedded trials,
and we determined the sample size for each separately.
Each trial required 80% power to detect a 10%
difference in adherence to guideline recommendations
(for example, between 45% and 55%) with a
significance level of 5%. Adherence to the guidelines
was defined by measures of process as recorded in the
patients’ records. Because the intraclass correlation
coefficients for measures of process were estimated to
be around 0.05, we collected data from 40 patients with
each condition in each of 60 practices.9 We assessed
changes in patient outcome with summated Likert
scales that could be considered as continuous variables
with a normal distribution. Again, we assumed an
intraclass correlation coefficient of 0.05.9 Application
of standard methods indicated that if we collected data
from 40 patients from each of 60 practices we would
have 80% power to detect an effect size of 0.2 standard
deviations with a significance of 5%.10
Data collection
We collected process data from patients’ records at the
end of the intervention period for the 24 months from
12 months before to 12 months after the introduction
of the computerised decision support system. Prescrib›
ing data were abstracted electronically from computer›
ised clinical records. Trained data collectors, blinded to
practice allocation, manually abstracted non›
prescribing data from the patients’ written and compu›
terised records.
We gathered patient reported outcomes and
economic data from three rounds of postal question›
naires. We posted questionnaires 12 months before the
intervention, immediately before the intervention, and
12 months after the intervention. We used a combina›
tion of generic (SF›36 and the EQ›5D) and condition
specific measures of quality of life (the Seattle angina
questionnaire, the Newcastle asthma symptoms ques›
tionnaire, and the asthma quality of life
questionnaire).11–16
We collected data on three overlapping non›
identical samples of patients. To obtain 40 patients with
each condition per practice after three rounds of ques›
tionnaires, we drew a random sample of 80 eligible
patients with each condition per practice for the first
postal outcome survey. The dataset for patient
reported outcomes comprised all patients completing
all three questionnaires. The dataset for prescribing
comprised all patients who responded to the first out›
come survey. We gathered process data based on clini›
cal records for a random sample of 40 patients who
responded to the first outcome survey. A usage log
within the practice computers recorded when the
guidelines were used and by whom.
Analysis
We analysed data from the three patient samples inde›
pendently, and we analysed each condition separately.
We analysed each dataset in Stata, with generalised lin›
ear modelling procedures appropriate for hierarchical
data. We analysed binary variables, data in the form of
counts, and continuous outcome variables with binary,
Poisson, and normal error structures, respectively. We
modelled as random effects variation between prac›
tices and variation between patients (nested within
practices). We included as a fixed effect the effect of
decision support software.
We analysed each variable for clinical record based
data and prescribing data twice. We based a pragmatic
intention to treat analysis on all patients, whether or
not they had consulted. We restricted an explanatory
analysis to those patients who consulted after
implementation of the system and for whom there was
thus an opportunity for the intervention to influence
their management.
All primary care practices in
north east England
(n=1067)
Not invited to participate
because ineligible
computer system or single-
handed practice
(n=742)
Declined to participate
(n=205)
Selected for case study
(n=6)
Declined to join trial
(n=17)
Not eligible because of low
levels of computer use or
concurrent use of study
guidelines or another computer
decision support system
(n=35)
Invited to participate
(n=325)
Interested in participating
(n=120)
Eligible to participate
(n=85)
Invited to join trial
(n=79)
Provided round 1 postal
survey data
(n=62)
Randomised to
angina guidelines
(n=31)
Randomised to
asthma guidelines
(n=31)
Completed study
(n=29)
Withdrew
from trial
(n=2)
Completed study
(n=31)
Fig 1 Flow of practices through trial
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Intervention
Computerised decision support system
The computerised decision support system was based
on pre›existing software that was currently available to
support prescribing for acute conditions.17 The two
suppliers of the practice computer systems integrated
the software into their products. The system antici›
pated clinicians’ requirements by using information
contained within a patient’s computerised record to
trigger the guideline and present patient scenarios—for
example, for asthma, review of stable patient or acute
exacerbation. Based on the chosen scenario, the system
offered suggestions for management (including pre›
scribing) informed by the content of the patient’s
record and requested the entry of relevant infor›
mation, which was then stored in the patient’s record.
The guideline was, however, a separate path within the
clinical system, and it was not possible to access all
other parts of the clinical system from within the
guideline. If the guideline was exited, it was only possi›
ble to return to it at the beginning of the pathway. The
system was triggered either automatically by entering
the electronic record of a patient previously identified
as eligible or by entering a relevant morbidity code.
After 4 months (based on feedback from practices) the
system was altered so that triggering occurred only in
response to a relevant morbidity code.
Training
Immediately before the intervention period each prac›
tice was invited to send two members to a one day
workshop on using the system (training materials were
supplied). Each doctor or practice nurse in the study
received a paper copy of the summary of both
guidelines, and each practice received a paper copy of
the full version of both guidelines.
Results
Figure 1 shows the flow of practices through the trial.
Six eligible practices were selected for an embedded
case study, which is reported elsewhere.5 One practice
(randomised to the asthma guideline) upgraded their
system software and was unable to provide data on
prescribing.
Participating general practices and patient samples
Table 1 shows the characteristics of the participating
practices. The randomised groups were of similar size
and vocational training status, and there were no
differences in any aspect of practice organisation or
Table 1 Characteristics of general practices randomised to receive guidelines on management of angina or asthma. Values are means
(standard deviations)
Randomised to
angina guideline
Randomised to
asthma guideline Overall
Whole time equivalent general practitioner 4.5 (1.6) 4.6 (1.8) 4.5 (1.7)
No of patients registered with practice 7837 (3221) 8875 (4460) 8365 (3902)
No of patients per whole time equivalent general practitioner 1760 (299) 1839 (344) 1800 (322)
No of patients booked per hour with general practitioner 7.7 (1.9) 8.6 (2.8) 8.1 (2.4)
General practitioner consultation time (min) 8.2 (1.8) 7.6 (2.1) 7.9 (1.9)
Extra patients booked per general practitioner per surgery 2.7 (1.8) 3.1 (3.8) 2.9 (2.9)
No of patients booked per hour with practice nurse 6.1 (1.9) 6.4 (3.1) 6.2 (2.5)
Practice nurse consultation time (min) 11 (4.5) 11.1 (4.3) 11.1 (4.4)
Electronically abstracted
prescribing data
Patient reported outcome data
Recruited practices
(n=62)
Randomised to
receive angina
guidelines
(n=31)
Withdrew
(n=2)
Withdrew
(n=2)
Unable to supply
data (n=1)
Withdrew
(n=2)
Randomised to
receive asthma
guidelines
(n=31)
Randomised to
receive angina
guidelines
(n=31)
Randomised to
receive asthma
guidelines
(n=31)
Randomised to
receive angina
guidelines
(n=31)
Randomised to
receive asthma
guidelines
(n=31)
Recruited practices
(n=62)
Outcome data round 1 (n=62)
Mean (range) patients per practice
Angina
56.7 (15-70)
Asthma
49.3 (35-64)
Outcome data round 3 (n=29)
Mean (range) patients per practice
Angina
36.9 (9-47)
Asthma
28.8 (10-43)
Outcome data round 3 (n=31)
Mean (range) patients per practice
Angina
37.8 (13-51)
Asthma
29.9 (14-42)
Provided process data
(n=29)
Mean (range) patients
per practice
Angina
38.5
(12-41)
Asthma
40.1
(37-42)
Provided process data
(n=31)
Mean (range) patients
per practice
Angina
39.3
(15-50)
Asthma
38.7
(21-41)
Provided drug data
(n=29)
Mean (range) patients
per practice
Angina
48.8
(12-59)
Asthma
47.8
(37-59)
Provided drug data
(n=30)
Mean (range) patients
per practice
Angina
48.9
(18-61)
Asthma
46.4
(18-57)
Outcome data round 2
(n=29)
Mean (range) patients
per practice
Angina
43.5
(13-54)
Asthma
35.2
(22-50)
Outcome data round 2
(n=31)
Mean (range) patients
per practice
Angina
44.3
(22-50)
Asthma
35.5
(20-45)
Manually abstracted
clinical record data
Fig 2 Data collected
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computer usage relevant to the care of patients with
angina or asthma.
Figure 2 summarises the data collected. Across all
three samples there were no significant differences in
the mean number of patients per practice between the
two study groups.
Clinical record data and prescribing data
Reliability coefficients of 0.73 to 1.00 were obtained
across the three data collectors for collection of 15 vari›
ables of process of care. No significant effects were found
of the computerised decision support system on consul›
tation rates, any aspect of the process of care for patients
with angina or asthma (tables 2 and 3), or prescription of
any category of drugs (tables 4 and 5). For all the
reported variables from the clinical records the
guidelines suggested that the action should be
performed, although at varying intervals ranging from
yearly to once only. For angina the guidelines
recommended the first line use of â blockers, with other
drugs being used in the case of intolerance or
inadequate control of symptoms. For asthma the guide›
lines recommended the appropriate use of all reported
drugs. As data collection related to two 12 month
periods the results will potentially underestimate less
frequently performed actions. It is also possible that
actions were performed but not recorded in the record.
Intraclass correlation coefficients were calculated for
each condition and are reported elsewhere.5
Patient reported outcomes
Overall, 4851 patients with angina and 4960 patients
with asthma were identified for the first survey of
patient outcomes, and 2241 (46%) patients with angina
and 1760 (35%) patients with asthma completed ques›
tionnaires in all three rounds (fig 2). Response rates to
the surveys were similar between the randomised
groups. The computerised guidelines showed no effect
on any patient reported outcome. For each condition
intraclass correlation coefficients were calculated for
each measure and each round and are reported
elsewhere.5
Usage log files
Figure 3 shows the number of times the guidelines
were triggered for each practice and the proportion of
active interactions that involved going beyond the first
screen. All data are standardised per whole time equiv›
alent general practitioner. For both suppliers, the
Table 2 Process of care for patients with angina based on clinical records before and after introduction of computerised decision
support system
Computerised system (n=1117) Controls (n=1218) Odds ratio (95% CI)
No of patients consulting during intervention period 1084 1192
Mean (SD) No of consultations during intervention period 8.5 (6.4) 8.6 (6.2) 1.01* (0.91 to 1.11)
Mean (SD) No of consultations for angina 1.6 (2.4) 1.6 (2.3) 1.05* (0.83 to 1.33)
No (%) of patients consulting before and after intervention period
Blood pressure recorded:
All patients 859 (77); 889(80) 935 (77); 969 (80) 1.01 (0.74 to 1.39)
Patients who consulted 859 (79); 889 (82) 935 (79); 969 (82) 1.05 (0.75 to 1.46)
Exercise recorded or advised:
All patients 99 (9); 113 (10) 156 (13); 153 (13) 0.91 (0.55 to 1.50)
Patients who consulted 99 (9); 113 (10) 156 (13); 153 (13) 0.90 (0.54 to 1.48)
Weight recorded or advised:
All patients 253 (23); 282 (26) 288 (24); 362 (30) 0.86 (0.54 to 1.35)
Patients who consulted 253 (23); 282 (26) 288 (24); 362 (30) 0.87 (0.55 to 1.37)
Smoking status known:
All patients 222 (20); 243 (22) 261 (22); 378 (32) 0.68 (0.42 to 1.11)
Patients who consulted 222 (20); 243 (22) 261 (22); 378 (32) 0.68 (0.41 to 1.13)
Smoking education given:
All patients 33 (3); 47 (4) 41 (3); 48 (4) 1.08 (0.86 to 1.77)
Patients who consulted 33 (3); 47 (4) 41 (3); 48 (4) 1.09 (0.66 to 1.78)
12 lead electrocardiogram recorded:
All patients 162 (15); 154 (14) 197 (16); 164 (14) 1.01 (0.68 to 1.52)
Patients who consulted† 84 (9) 93 (8) 0.94 (0.58 to 1.53)
Exercise electrocardiogram recorded:
All patients 46 (4); 28 (3) 46 (4); 30 (3) 1.01 (0.56 to 1.80)
Patients who consulted† 23 (2) 24 (2) 1.05 (0.56 to 1.98)
Haemoglobin concentration recorded:
All patients 322 (29); 371 (33) 355 (29); 400 (33) 1.01 (0.72 to 1.42)
Patients who consulted† 201 (29) 204 (26) 1.08 (0.74 to 1.56)
Thyroid function recorded:
All patients 192 (17); 214 (19) 215 (18); 264 (22) 0.83 (0.62 to 1.12)
Patients who consulted† 136 (16) 151 (16) 0.94 (0.67 to 1.33)
Cholesterol or other lipid concentrations recorded:
All patients 395 (35); 482 (43) 427 (35); 574 (47) 0.85 (0.65 to 1.12)
Patients who consulted† 482 (45) 572 (48) 0.87 (0.66 to 1.14)
Blood glucose or HbA1c concentrations recorded:
All patients 221 (20); 300 (27) 267 (22); 334 (27) 0.96 (0.67 to 1.39)
Patients who consulted† 300 (28) 334 (28) 0.97 (0.67 to 1.41)
*Effect sizes; estimates of ratio of mean number of consultations for participants in practices that received computerised decision support system to mean number
of consultations for participants in control practices based on Poisson regression model.
†Patients who consulted after intervention and had not had variable recorded anywhere in their clinical record during period before intervention.
Primary care
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median number of active interactions was zero for
much of the study.
Discussion
We found no effect of a computerised decision support
system as a vehicle for implementing evidence based
guidelines for the management of two chronic diseases
in primary care. We addressed the complexities of such
management where clinicians provide ongoing care
for patients with complex conditions and for extended
periods. At the time of its deployment the system was
embedded in two of the most widely used practice
computer systems in the United Kingdom and was
more sophisticated than any other commercially avail›
able to primary care facilities in the United Kingdom.
We were, however, unable to show any incremental
effect over the distribution of paper versions of the
guidelines across a comprehensive range of measures,
almost certainly due to the low levels of use.
A systematic review suggested caution in interpret›
ing the results of identified studies of computerised
decision support systems because of flaws in their
design or analysis, a common situation in studies on
Table 3 Process of care for patients with asthma based on clinical records before and after introduction of computerised decision
support system
Computerised system (n=1200) Controls (n=1163) Odds ratio (95% CI)
No of patients consulting during intervention period 1129 1101
Mean (SD) No of consultations during intervention period 6.7 (6.3) 6.8 (5.8) 1.01* (0.92 to 1.11)
Mean (SD) No of consultations for asthma 1.5 (2.3) 1.6 (2.2) 0.94* (0.81 to 1.08)
No (%) of patients consulting before and after intervention period
Lung function assessed:
All patients 516 (43); 511 (43) 492 (42); 517 (45) 0.94 (0.67 to 1.33)
Patients who consulted 515 (45); 510 (45) 491 (45); 516 (47) 0.94 (0.66 to 1.34)
Compliance checked:
All patients 426 (36); 442 (37) 446 (38); 471 (41) 0.82 (0.58 to 1.15)
Patients who consulted 425 (37); 441 (39) 445 (40); 470 (43) 0.82 (0.58 to 1.16)
Inhaler technique assessed:
All patients 203 (17); 224 (19) 234 (20); 262 (23) 0.8 (0.5 to 1.28)
Patients who consulted 203 (18); 224 (20) 233 (21); 262 (24) 0.81 (0.5 to 1.28)
Asthma education, action plan, or both:
All patients 79 (7); 60 (5) 108 (9); 78 (7) 0.84 (0.4 to 1.74)
Patients who consulted 79 (7); 60 (5) 108 (10); 78 (7) 0.81 (0.39 to 1.67)
Smoking status known:
All patients 285 (24); 370 (32) 305 (26); 367 (32) 0.97 (0.65 to 1.45)
Patients who consulted 285 (25); 369 (33) 303 (28); 367 (33) 0.98 (0.66 to 1.46)
Smoking cessation advice or nicotine replacement therapy:
All patients 57 (5); 81 (7) 68 (6); 103 (9) 0.75 (0.45 to 1.26)
Patients who consulted 57 (5); 81 (8) 68 (6); 103 (9) 0.76 (0.46 to 1.27)
*Effect size; see footnote to table 2.
Table 4 Drugs prescribed for patients with angina before and after introduction of computerised decision support system. Values are
numbers (percentages) of patients unless stated otherwise
Computerised system (n=1415) Controls (n=1466) Odds ratio (95% CI)
Short acting glyceryl trinitrate 813 (58); 806 (57) 831 (57); 802 (55) 1.11 (0.87 to 1.41)
â Blockers 666 (47); 683 (48) 712 (49); 718 (49) 0.99 (0.73 to 1.33)
Verapamil 21 (2); 24 (2) 18 (1); 21 (1) 1.02 (0.57 to 1.82)
Modified release glyceryl trinitrate 46 (3); 37 (3) 46 (3); 43 (3) 0.97 (0.50 to 1.54)
Transdermal glyceryl trinitrate 19 (1); 14 (1) 34 (2); 27 (2) 1.03 (0.54 to 1.98)
Isosorbide dinitrate (short acting and modified release) 64 (5); 56 (4) 86 (6); 79 (5) 0.91 (0.63 to 1.31)
Isosorbide mononitrate (short acting and modified release) 522 (37); 524 (37) 556 (38); 547 (37) 1.11 (0.79 to 1.56)
Diltiazem 270 (19); 269 (19) 310 (21); 287 (20) 1.43 (0.87 to 2.34)
Calcium channel blockers 396 (28); 380 (27) 377 (26); 368 (25) 1.12 (0.80 to 1.58)
Statins 409 (29); 498 (35) 435 (30); 550 (38) 0.92 (0.67 to 1.25)
â Blocker and dinitrate* 20 (1); 20 (1) 34 (2); 30 (2) 1.24 (0.66 to 2.33)
Calcium blocker and dinitrate* 22 (2); 24 (2) 41 (3); 37 (3) 1.15 (0.68 to 1.95)
Nitrate, calcium blocker, and â blocker* 113 (8); 102 (7) 115 (8); 120 (8) 0.75 (0.46 to 1.22)
*Guideline specifically recommended not using these combinations.
Table 5 Drugs prescribed for patients with asthma before and after introduction of computerised decision support system. Values are
numbers (percentages) unless stated otherwise
Computerised system (n=1391) Controls (n=1385) Odds ratio (95% CI)
Short acting â2 agonists 1138 (82); 1112 (80) 1160 (84); 1108 (80) 1.04 (0.83 to 1.31)
Inhaled corticosteroids 1065 (77); 1001 (72) 1004 (73); 975 (70) 0.95 (0.78 to 1.16)
Long acting â2 agonists 181 (13); 198 (14) 164 (12); 183 (13) 0.84 (0.59 to 1.20)
Oral steroids 317 (23); 316 (23) 286 (21); 297 (21) 1.0 (0.82 to 1.22)
Oral bronchodilators 100 (7); 95 (7) 120 (9); 119 (9) 1.38 (0.56 to 3.39)
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changing professional behaviour.3 18 However, we
addressed all of the important issues for design,
conduct, and analysis.4 19
Asthma and angina are common chronic diseases
in primary care. Both are of low incidence so
dimensions of care such as initial investigations would
be infrequent and less likely to be affected by any
method of guideline implementation. Much of both
guidelines dealt with the ongoing management of
established cases, and the low incidence of both condi›
tions should not have affected this. None the less, there
are areas of care that an interactive computerised deci›
sion support system may be less able to influence, such
as the issuing of routine repeat prescriptions by
administrative staff. However, good clinical practice
suggests that most patients with angina or asthma
should receive an annual review, and within the trial
almost all the patients consulted sufficiently frequently
for this to have been considered. Although the
guidelines reflected much of current practice—and
performance of some actions may have been close to
optimal (for example, use of short acting â2 agonists)—
they both made recommendations for management
that were not routine at the time of the study. Therefore
it is unlikely that the guidelines merely enshrined all of
current practice, and the data on process of care before
the intervention show that this was not the case.
Although the study practices were selected on the
basis of the extensive use of their computer systems
(and thus were most likely to use a computerised deci›
sion support system), the staff had limited training in
the functioning and use of the system. Limiting the
amount of training in our study to one day was a prag›
matic decision based on resources but was not that far
removed from what is routine computer training
within primary care in the United Kingdom.
For most general practitioners in the study the
computerised system functioned in the context of rou›
tine surgeries (as opposed to settings such as clinics
dedicated to disease management). Patients could
present with any clinical problem such as arthritis or
depression and, despite having asthma or angina,
might not wish to discuss this, even though the compu›
terised system might suggest this was appropriate.
Given the range and complexity of problems that
patients present to general practitioners it is demand›
ing for any system to function in an unobtrusive yet
helpful manner. The negative findings and low levels of
use in our trial are similar to those observed by Hetle›
vik et al, who evaluated a computerised decision
support system for the management of patients with
hypertension or diabetes in primary care.20 21 They
found that the guideline was used in the management
of only 12% of patients with diabetes.21
Assuming that the technical challenges of produc›
ing a system that truly supports the management of
complex disease can be overcome there remains the
problem of how such systems function within clinical
encounters where patients with complex conditions
are managed. “To be widely accepted by practising cli›
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nicians, computerised support systems for decision
making must be integrated into the clinical workflow.
They must present the right information, in the right
format, at the right time, without requiring special
effort.”22 It is at least possible that for some or all of the
reasons discussed above the low levels of use are all
that can be reasonably expected of a computerised
decision support system for the management of
chronic disease.21 Certainly, in terms of implementing
evidence based care, computerisation seems unlikely
ever to be the “magic bullet” that answers all questions,
and the current system could not be recommended.23
Although an increasing number of studies show that
computerised decision support systems can function in
a variety of circumstances, the challenge still remains to
show how far this is possible, desirable, and efficient.3
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What is already known on this topic
Computerised decision support systems produce
improvements in patient care across a range of
conditions and settings
Previous evaluations have been undermined by
flaws in study design
Few studies have evaluated complex decision
support systems for the management of chronic
disease
What this study adds
No impact was found of a computerised decision
support system delivering evidence based
guidelines for chronic diseases on either the
process or outcomes of care
It is unclear whether there are benefits from
integrating such systems into clinical encounters
where busy practitioners manage patients with
complex and multiple conditions
Primary care
page 7 of 7BMJ VOLUME 325 26 OCTOBER 2002 bmj.com
